Package 75834-338-02

Brand: diclofenac potassium

Generic: diclofenac potassium
NDC Package

Package Facts

Identity

Package NDC 75834-338-02
Digits Only 7583433802
Product NDC 75834-338
Description

9 POWDER, FOR SOLUTION in 1 CARTON (75834-338-02)

Marketing

Marketing Status
Marketed Since 2025-12-15
Brand diclofenac potassium
Generic diclofenac potassium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "46982e49-ee38-ad56-e063-6394a90a2816", "openfda": {"unii": ["L4D5UA6CB4"], "rxcui": ["859063"], "spl_set_id": ["eb52a015-23cd-40f6-bf83-6749fc34947c"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POWDER, FOR SOLUTION in 1 PACKET (75834-338-01)", "package_ndc": "75834-338-01", "marketing_start_date": "20251215"}, {"sample": false, "description": "9 POWDER, FOR SOLUTION in 1 CARTON (75834-338-02)", "package_ndc": "75834-338-02", "marketing_start_date": "20251215"}], "brand_name": "DICLOFENAC POTASSIUM", "product_id": "75834-338_46982e49-ee38-ad56-e063-6394a90a2816", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "75834-338", "generic_name": "Diclofenac potassium", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DICLOFENAC POTASSIUM", "active_ingredients": [{"name": "DICLOFENAC POTASSIUM", "strength": "50 mg/1"}], "application_number": "ANDA217010", "marketing_category": "ANDA", "marketing_start_date": "20251215", "listing_expiration_date": "20261231"}